Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicenter, Prospective, Randomized, Single Blind, Cross-Over Study on the Effect of a Fixed Combination of Citicoline 500 mg Plus Homotaurine 50 mg on Pattern Electroretinogram (PERG) in Patients With Open Angle Glaucoma on Well Controlled Intraocular Pressure.
Rossi GCM, Rolle T, De Silvestri A, Sisto D, Mavilio A, Mirabile AV, Paviglianiti A, Strano B, Picasso E, Pasinetti GM, Milano G, Ruberto G. Rossi GCM, et al. Among authors: pasinetti gm. Front Med (Lausanne). 2022 Apr 29;9:882335. doi: 10.3389/fmed.2022.882335. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35572982 Free PMC article.
Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram.
Rossi GCM, Scudeller L, Lumini C, Bettio F, Picasso E, Ruberto G, Briola A, Mirabile A, Paviglianiti A, Pasinetti GM, Bianchi PE. Rossi GCM, et al. Among authors: pasinetti gm. Sci Rep. 2020 Jun 26;10(1):10468. doi: 10.1038/s41598-020-67527-z. Sci Rep. 2020. PMID: 32591562 Free PMC article. Clinical Trial.
Monitoring adherence rates in glaucoma patients using the Travatan Dosing Aid. A 6-month study comparing patients on travoprost 0.004% and patients on travoprost 0.004%/timolol 0.5% fixed combination.
Rossi GC, Pasinetti GM, Scudeller L, Tinelli C, Milano G, Bianchi PE. Rossi GC, et al. Among authors: pasinetti gm. Expert Opin Pharmacother. 2010 Mar;11(4):499-504. doi: 10.1517/14656561003601994. Expert Opin Pharmacother. 2010. PMID: 20163264 Clinical Trial.
Signs and symptoms of ocular surface status in glaucoma patients switched from timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month efficacy and tolerability, multicenter, open-label prospective study.
Rossi GC, Tinelli C, Pasinetti GM, Fusetti M, Pallavicini C, Stringa M, Vacchi S, Stringa F, Bianchi PE. Rossi GC, et al. Among authors: pasinetti gm. Expert Opin Pharmacother. 2011 Apr;12(5):685-90. doi: 10.1517/14656566.2011.557361. Epub 2011 Mar 9. Expert Opin Pharmacother. 2011. PMID: 21385109
Efficacy and ocular surface tolerability of preservative-free tafluprost 0.0015%: a 6-month, single-blind, observational study on naïve ocular hypertension or glaucoma patients.
Rossi GC, Pasinetti GM, Raimondi M, Ricciardelli G, Scudeller L, Blini M, Amisano A, Bianchi PE. Rossi GC, et al. Among authors: pasinetti gm. Expert Opin Drug Saf. 2012 Jul;11(4):519-25. doi: 10.1517/14740338.2012.690734. Epub 2012 Jun 13. Expert Opin Drug Saf. 2012. PMID: 22690824
281 results